$3.83 Billion is the total value of Third Security, LLC's 21 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | INTREXON CORP | $3,012,164,000 | +7.6% | 61,724,682 | 0.0% | 78.75% | -0.1% | |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $447,746,000 | +58.2% | 19,829,337 | +0.1% | 11.71% | +47.0% |
| ZIOP | Sell | ZIOPHARM ONCOLOGY INC | $115,989,000 | -44.1% | 9,665,742 | -49.8% | 3.03% | -48.1% |
| FCSC | FIBROCELL SCIENCE INC | $82,446,000 | +16.9% | 15,644,427 | 0.0% | 2.16% | +8.6% | |
| SYN | SYNTHETIC BIOLOGICS INC | $35,057,000 | +30.1% | 12,300,768 | 0.0% | 0.92% | +21.0% | |
| EPD | ENTERPRISE PRODS PARTNERS L | $30,961,000 | -9.2% | 1,035,834 | 0.0% | 0.81% | -15.7% | |
| ET | ENERGY TRANSFER EQUITY L P | $24,141,000 | +1.3% | 376,200 | 0.0% | 0.63% | -6.0% | |
| HSGX | HISTOGENICS CORP | $17,381,000 | -35.3% | 2,690,570 | 0.0% | 0.45% | -39.9% | |
| OGEN | ORAGENICS INC | $13,480,000 | +34.3% | 9,839,221 | 0.0% | 0.35% | +24.8% | |
| OVAS | OVASCIENCE INC | $10,797,000 | -16.7% | 373,224 | 0.0% | 0.28% | -22.7% | |
| GEL | GENESIS ENERGY L Punit ltd partn | $9,524,000 | -6.6% | 217,000 | 0.0% | 0.25% | -13.2% | |
| NS | NUSTAR ENERGY LP | $6,914,000 | -2.2% | 116,500 | 0.0% | 0.18% | -9.0% | |
| TCP | TC PIPELINES LP | $5,529,000 | -12.5% | 97,000 | 0.0% | 0.14% | -18.5% | |
| MMLP | MARTIN MIDSTREAM PRTNRS L Punit l p int | $4,390,000 | -12.6% | 141,800 | 0.0% | 0.12% | -18.4% | |
| ETP | New | ENERGY TRANSFER PRTNRS L Punit ltd partn | $4,052,000 | – | 77,634 | +100.0% | 0.11% | – |
| CMLP | CRESTWOOD MIDSTREAM PARTNERSunit ltd partner | $3,188,000 | -22.8% | 284,620 | 0.0% | 0.08% | -28.4% | |
| TBIO | TRANSGENOMIC INC | $1,287,000 | +15.9% | 770,490 | 0.0% | 0.03% | +9.7% | |
| RGP | Exit | REGENCY ENERGY PARTNERS L P | $0 | – | -188,250 | -100.0% | -0.12% | – |
| PAA | Exit | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $0 | – | -400,000 | -100.0% | -0.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HALOZYME THERAPEUTICS INC | 36 | Q1 2022 | 37.6% |
| TC PIPELINES LP | 30 | Q3 2020 | 1.1% |
| ENTERPRISE PRODS PARTNERS L | 29 | Q2 2020 | 6.7% |
| ENERGY TRANSFER LP | 29 | Q2 2020 | 2.7% |
| NUSTAR ENERGY LP | 29 | Q2 2020 | 1.3% |
| INTREXON CORP | 26 | Q4 2019 | 82.5% |
| ZIOPHARM ONCOLOGY INC | 25 | Q2 2020 | 7.5% |
| AQUABOUNTY TECHNOLOGIES INC | 23 | Q3 2022 | 16.9% |
| SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 4.0% |
| ORAGENICS INC | 19 | Q4 2017 | 3.9% |
View Third Security, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Third Security, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.